Kenara Blocker
Family · Tallahassee, FLNPI 1578038675
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 141 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 17 manufacturers, the largest accounting for just 20.6% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2021 at $1,735 and has fallen 95.6% since, to $77 in 2025.
Across 141 payments — averaging $19.80 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$576
- Takeda Pharmaceuticals U.S.A., Inc.$398
- Sunovion Pharmaceuticals Inc.$298
- Teva Pharmaceuticals USA, Inc.$213
- Otsuka America Pharmaceutical, Inc.$175
- Vanda Pharmaceuticals Inc.$167
- plus $965 from 11 others
What the payments were for
- Food & beverage$2,792100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 36 | $576 |
| Takeda Pharmaceuticals U.S.A., Inc. | 23 | $398 |
| Sunovion Pharmaceuticals Inc. | 14 | $298 |
| Teva Pharmaceuticals USA, Inc. | 11 | $213 |
| Otsuka America Pharmaceutical, Inc. | 9 | $175 |
| Vanda Pharmaceuticals Inc. | 7 | $167 |
| Neurocrine Biosciences, Inc. | 3 | $164 |
| Eisai Inc. | 4 | $130 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 7 | $123 |
| Merck | 7 | $115 |
| Jazz Pharmaceuticals Inc. | 5 | $99 |
| Neos Therapeutics, LP | 4 | $79 |
| Viiv Healthcare Company | 1 | $77 |
| Almatica Pharma LLC | 5 | $76 |
| Alkermes, Inc. | 2 | $43 |
| Lundbeck LLC | 2 | $38 |
| OWP Pharmaceuticals, Inc. | 1 | $20 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- INGREZZA$120
How this compares
$2,792 in reported general payments places this provider in the 85th percentile of 14,618 family providers in Florida.
Other family in Tallahassee
- Kathleen WilsonTallahassee$154K
- Brittany YatesTallahassee$73K
- Lewis HarringtonTampa$954K
- Danielle PharesFt Lauderdale$713K
- Donna OrtizOrlando$417K
- Patrick SzarazMiami$327K
- Deena RodneyMaitland$323K
- Yamila MelendezMiami$212K
- Holly BoydLand O Lakes$200K
- Rachael BuschLoxahatchee$189K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.